Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre‐ and post‐unrestricted availability of direct acting antiviral therapies.
Aims: The 2016 Global Health Sector Strategy (GHSS) on viral hepatitis aims to reduce new hepatitis C virus (HCV) infections by 80% by 2030, including a 30% reduction by 2020. This study aimed to estimate primary HCV incident infection among a national sample of people who inject drugs (PWID) before...
| Publicado en: | Addiction Vol. 118; no. 5; pp. 901 - 912 |
|---|---|
| Autores principales: | , , , , |
| Formato: | research tables/charts Journal Article |
| Publicado: |
Wiley-Blackwell
May2023
|
| Acceso en línea: | Ver este registro en EBSCOhost |